Physician profile
Anne Mcgee
NPI 1043986185
$2,209.92
in general payments reported to CMS, 2019-2025
9 companies · $216 in 2025
The $216 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $282 · 2022: $372 · 2023: $762 · 2024: $579 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,356 · Education: $200.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,356.37 |
| Education | $199.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $817.60 | 2022-2025 | Wakix |
| Jazz Pharmaceuticals INC. | $730.64 | 2021-2024 | |
| Axsome Therapeutics, INC. | $176.58 | 2022-2025 | Sunosi |
| Chiesi USA, INC. | $168.07 | 2021 | |
| Abbvie INC. | $117.73 | 2025 | |
| Avadel Cns Pharmaceuticals, LLC | $70.54 | 2023-2024 | Lumryz |
| Idorsia Pharmaceuticals US INC | $64.79 | 2023-2024 | Quviviq |
| Fisher & Paykel Healthcare INC | $33.16 | 2024 | Fisher & Paykel Healthcare |
| Novartis Pharmaceuticals Corporation | $30.81 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anne Mcgee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.